Cargando…
Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension
Clinical trials have failed to demonstrate an effective preventative or therapeutic strategy for bronchopulmonary dysplasia (BPD), a multifactorial chronic lung disease in preterm infants frequently complicated by pulmonary hypertension (PH). Mesenchymal stem cells (MSCs) and their secreted componen...
Autores principales: | Hansmann, Georg, Fernandez-Gonzalez, Angeles, Aslam, Muhammad, Vitali, Sally H., Martin, Thomas, Mitsialis, S. Alex, Kourembanas, Stella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401871/ https://www.ncbi.nlm.nih.gov/pubmed/22837858 http://dx.doi.org/10.4103/2045-8932.97603 |
Ejemplares similares
-
Paving the Road for Mesenchymal Stem Cell-Derived Exosome Therapy in Bronchopulmonary Dysplasia and Pulmonary Hypertension
por: Yeung, Vincent, et al.
Publicado: (2019) -
Pulmonary hypertension in bronchopulmonary dysplasia
por: Hansmann, Georg, et al.
Publicado: (2020) -
Macrophage Immunomodulation: The Gatekeeper for Mesenchymal Stem Cell Derived-Exosomes in Pulmonary Arterial Hypertension?
por: Willis, Gareth R., et al.
Publicado: (2018) -
NOVEL BIOMARKERS OF BRONCHOPULMONARY DYSPLASIA AND BRONCHOPULMONARY DYSPLASIA-ASSOCIATED PULMONARY HYPERTENSION
por: Sahni, Mitali, et al.
Publicado: (2020) -
Therapeutic Effects of Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles in Oxygen-Induced Multi-Organ Disease: A Developmental Perspective
por: Fernandez-Gonzalez, Angeles, et al.
Publicado: (2021)